35 related articles for article (PubMed ID: 24161672)
21. TRAIL-activated EGFR by Cbl-b-regulated EGFR redistribution in lipid rafts antagonises TRAIL-induced apoptosis in gastric cancer cells.
Xu L; Zhang Y; Liu J; Qu J; Hu X; Zhang F; Zheng H; Qu X; Liu Y
Eur J Cancer; 2012 Nov; 48(17):3288-99. PubMed ID: 22456178
[TBL] [Abstract][Full Text] [Related]
22. Oxaliplatin enhances TRAIL-induced apoptosis in gastric cancer cells by CBL-regulated death receptor redistribution in lipid rafts.
Xu L; Qu X; Zhang Y; Hu X; Yang X; Hou K; Teng Y; Zhang J; Sada K; Liu Y
FEBS Lett; 2009 Mar; 583(5):943-8. PubMed ID: 19223002
[TBL] [Abstract][Full Text] [Related]
23. Formation of the IGF1R/CAV1/SRC tri-complex antagonizes TRAIL-induced apoptosis in gastric cancer cells.
Guo T; Xu L; Che X; Zhang S; Li C; Wang J; Gong J; Ma R; Fan Y; Hou K; Zhou H; Hu X; Liu Y; Qu X
Cell Biol Int; 2017 Jul; 41(7):749-760. PubMed ID: 28403518
[TBL] [Abstract][Full Text] [Related]
24. Src/caveolin-1-regulated EGFR activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.
Xu L; Qu X; Li H; Li C; Liu J; Zheng H; Liu Y
Oncol Rep; 2014 Jul; 32(1):318-24. PubMed ID: 24840271
[TBL] [Abstract][Full Text] [Related]
25. DR5-Cbl-b/c-Cbl-TRAF2 complex inhibits TRAIL-induced apoptosis by promoting TRAF2-mediated polyubiquitination of caspase-8 in gastric cancer cells.
Xu L; Zhang Y; Qu X; Che X; Guo T; Li C; Ma R; Fan Y; Ma Y; Hou K; Li D; Hu X; Liu B; Yu R; Yan H; Gong J; Liu Y
Mol Oncol; 2017 Dec; 11(12):1733-1751. PubMed ID: 28972304
[TBL] [Abstract][Full Text] [Related]
26. Lipid raft-regulated IGF-1R activation antagonizes TRAIL-induced apoptosis in gastric cancer cells.
Xu L; Qu X; Hu X; Zhu Z; Li C; Li E; Ma Y; Song N; Liu Y
FEBS Lett; 2013 Nov; 587(23):3815-23. PubMed ID: 24161672
[TBL] [Abstract][Full Text] [Related]
27. The nuclear translocation of insulin-like growth factor receptor and its significance in cancer cell survival.
Chughtai S
Cell Biochem Funct; 2020 Jun; 38(4):347-351. PubMed ID: 31875653
[TBL] [Abstract][Full Text] [Related]
28. Strength and duration of GIPC-dependent signaling networks as determinants in cancer.
Ahmed T; Mythreye K; Lee NY
Neoplasia; 2021 Feb; 23(2):181-188. PubMed ID: 33360508
[TBL] [Abstract][Full Text] [Related]
29. IGF/IGF-1R signal pathway in pain: a promising therapeutic target.
Ma L; Zhao W; Huang S; Xu F; Wang Y; Deng D; Zhang T; Shu S; Chen X
Int J Biol Sci; 2023; 19(11):3472-3482. PubMed ID: 37497005
[TBL] [Abstract][Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
31.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
32.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
33.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
